雷公藤甲素唱硬脂酸酯的合成及其制剂成药性研究

傅志勤; 许幼发; 陈炳辰; 程丹; 马娟娟; 陈建明

doi:10.3969/j.issn.1006-0111.2017.02.011

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

雷公藤甲素唱硬脂酸酯的合成及其制剂成药性研究

傅志勤, 许幼发, 陈炳辰, 程丹, 马娟娟, 陈建明

文章导航 > 药学实践与服务 > 2017 > 35(2): 141-145

傅志勤, 许幼发, 陈炳辰, 程丹, 马娟娟, 陈建明. 雷公藤甲素唱硬脂酸酯的合成及其制剂成药性研究[J]. 药学实践与服务, 2017, 35(2): 141-145. doi: 10.3969/j.issn.1006-0111.2017.02.011

引用本文:

FU Zhiqin, XU Youfa, CHEN Bingchen, CHENG Dan, MA Juanjuan, CHEN Jianming. Synthesis and druggability study of triptolide stearate[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 141-145. doi: 10.3969/j.issn.1006-0111.2017.02.011

Citation:

FU Zhiqin, XU Youfa, CHEN Bingchen, CHENG Dan, MA Juanjuan, CHEN Jianming. Synthesis and druggability study of triptolide stearate[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 141-145. doi: 10.3969/j.issn.1006-0111.2017.02.011

雷公藤甲素唱硬脂酸酯的合成及其制剂成药性研究

doi: 10.3969/j.issn.1006-0111.2017.02.011

1.
福建中医药大学药学院, 福建福州 350122;第二军医大学药学院, 上海 200433
2.
第二军医大学学员旅学员6队, 上海 200433
3.
第二军医大学药学院, 上海 200433

Synthesis and druggability study of triptolide stearate

1.
School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China;School of Pharmacy, Second Military Medical University, Shanghai 200433, China
2.
The sixth Team of Student Brigade, Second Military Medical University, Shanghai 200433, China
3.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China

摘要: 目的合成一种雷公藤甲素脂溶性前药，以期提高其制剂的成药性。方法以4-二甲氨基吡啶（DMAP）催化的酸与醇的DCC缩合法，合成雷公藤甲素-硬脂酸酯（TP-SA），通过质谱、核磁共振氢谱和碳谱进行结构确认；采用摇瓶法测定化合物油-水分配系数；将TP及TP-SA制备成脂质体及脂肪乳，考察其初步稳定性。结果实验结果证明：成功合成TP-SA。TP-SA的log P为2.33。相同处方条件下，TP难以制备成脂质体和乳剂；TP-SA制备成脂质体粒径约90 nm，制备成脂肪乳粒径约110 nm，包封率均大于95%；4℃及25℃条件下观察TP-SA脂质体和脂肪乳的放置稳定性，1周内粒径、包封率等制剂参数皆无明显变化。结论 TP-SA显著改善药物制剂成药性，本研究可为TP制剂开发提供参考。
- 雷公藤甲素 /
- 硬脂酸酯 /
- 前药 /
- 脂质体 /
- 脂肪乳 /
- 成药性
Abstract: Objective To synthesize a lipophilic prodrug of triptolide (TP) and improve its druggability. Methods Triptolide stearate (TP-SA) was synthesized via the DMAP-catalyzed DCC method and identified by MS, ¹H-NMR and ¹³C-NMR. The shake-flask method was used to study the oil/water partition coefficient. The preparations of TP and TP-SA liposomes and emulsions were compared. Their encapsulation efficiency and stability were investigated. Results TP-SA was synthesized successfully. Its log P in octanol/water system was 2.33. It was difficult to prepare TP liposome or emulsion. By contrast, TP-SA liposome and emulsion can be prepared successfully with the same formulation process. The particle size of TP-SA liposomes were about 90 nm and TP-SA emulsions were about 110 nm. The encapsulation efficiency was above 95%. Their stability were studied at 4℃ and 25℃. The preparation parameters, such as particle size and encapsulation efficiency, had no significant change in a week. Conclusion Triptolide stearate enhanced drug lipophilicity. Its druggability was improved significantly. These data can be used for the TP related drug design and development.
- triptolide stearate /
- prodrug /
- liposome /
- emulsion /
- druggability /

[1]	Liu Q. Triptolide and its expanding multiple pharmacological functions[J]. Int Immunopharmacol,2011,11(3):377-383.
[2]	Wang CY,Bai XY,Wang CH. Traditional Chinese medicine:a treasured natural resource of anticancer drug research and development[J]. Am J Chin Med,2014,42(3):543-559.
[3]	Li XJ,Jiang ZZ,Zhang LY. Triptolide:Progress on research in pharmacodynamics and toxicology[J]. J Ethnopharmacol,2014,155(1):67-79.
[4]	Himes R,Lee S,Mcmenigall K,et al. Reduction in inflammation in the footpad of carrageenan treated mice following the topical administration of anti-TNF molecules formulated in a micro-emulsion[J]. J Control Release,2010,145(3):210-223.
[5]	Slingerland M,Guchelaar HJ,Gelderblom H. Liposomal drug formulations in cancer therapy:15 years along the road[J]. Drug Discov Today,2012,17(3-4):160-166.
[6]	姚媛,廖琼峰,曾丽英,等. 穿心莲内酯和脱水穿心莲内酯表观油水分配系数的测定及pH值对其的影响[J]. 中药材,2009,32(10):1610-1612.
[7]	宋桂军,柳菡,冯芳,等. 替米沙坦油水分配系数的测定及其意义[J]. 药物分析杂志,2007,27(11):1704-1706.
[8]	吕文莉,郭健新,平其能. 灯盏花素脂质体的制备及其理化性质的测定[J]. 中国天然药物,2004,2(5):289-292.
[9]	何海冰,殷春阳,徐丽双,等. 丁酸氯维地平亚微乳注射液的制备与理化性质考察[J]. 沈阳药科大学学报,2015,32(10):760-766.
[10]	陶小妹,张强,顾红燕,等. 共轭亚油酸-吉西他滨脂质体的制备、表征及体外抗肿瘤活性[J]. 中国新药杂志,2016,25(10):1177-1185.
[11]	庄莹,宋敏,杭太俊,等. 雷公藤多苷片中雷公藤总内酯及雷公藤内酯醇的测定[J]. 药物分析杂志,2008,28(1):36-40.
[12]	Zhou ZL,Yang YX,Ding J,et al. Triptolide:structural modifications,structure-activity relationships,bioactivities,clinical development and mechanisms[J]. Nat Prod Rep,2012,29(4):457-475.

[1]	竺东杰, 贺新征, 邹杰, 余史丹, 李红霞. 雷公藤甲素对大鼠脑缺血再灌注损伤的影响及机制研究 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202311021
[2]	高习清, 卢光照, 鲁莹, 邹豪. 活性氧自由基响应型脂质体在抗肿瘤研究中的应用进展 . 药学实践与服务, 2023, 41(1): 14-17. doi: 10.12206/j.issn.2097-2024.202105086
[3]	何晓莉, 施艺玮, 陈兰, 刘悦, 洪战英. 基于心血管芯片模型的4种深海毒素致伤评价与雷公藤甲素的保护作用研究 . 药学实践与服务, 2023, 41(3): 149-154, 159. doi: 10.12206/j.issn.2097-2024.202206018
[4]	高习清, 卢光照, 鲁莹, 邹豪. 光敏ROS响应型雷帕霉素脂质体的制备及表征 . 药学实践与服务, 2022, 40(5): 437-441. doi: 10.12206/j.issn.2097-2024.202110051
[5]	黄思凡, 张元声, 陈建明, 武鑫. 去甲斑蝥素新型制剂研究进展 . 药学实践与服务, 2021, 39(1): 1-3, 8. doi: 10.12206/j.issn.1006-0111.202004038
[6]	方夏琴, 檀华进, 谭晓川, 李鹤, 张宇佳, 郑稳生. 利巴韦林脂质体吸入粉雾剂的研制与初步评价 . 药学实践与服务, 2020, 38(6): 539-542. doi: 10.12206/j.issn.1006-0111.202004077
[7]	施磊, 叶隽, 宋磊. 紫草素钠脂质体的制备及性能研究 . 药学实践与服务, 2019, 37(1): 69-73. doi: 10.3969/j.issn.1006-0111.2019.01.016
[8]	王晶, 张川, 栗意, 任金妹, 唐扣明. 用HPLC法测定丹参素棕榈醇酯脂质体药物含量 . 药学实践与服务, 2019, 37(5): 450-452,480. doi: 10.3969/j.issn.1006-0111.2019.05.012
[9]	巩志荣, 何文婷, 孙治国, 郭海霞, 钟延强, 鲁莹. 盐霉素钠纳米脂质体的制备及表征 . 药学实践与服务, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009
[10]	陈丽娜, 陈建明. 难溶性药物logP值对纳米脂肪乳载药特性的影响 . 药学实践与服务, 2015, 33(6): 513-517. doi: 10.3969/j.issn.1006-0111.2015.06.009
[11]	李莎, 仵文英, 徐晓娜, 李兴华, 马小亚. 正交试验优选硫酸铵梯度法制备苦参碱脂质体的工艺研究 . 药学实践与服务, 2013, 31(4): 286-289. doi: 10.3969/j.issn.1006-0111.2013.04.013
[12]	陈浩, 戴俊东, 王玉蓉, 祝年青, 孙毅坤, 王玥, 龚卫红. 薄膜超声法制备槲皮素脂质体研究 . 药学实践与服务, 2012, 30(1): 32-34. doi: 10.3969/j.issn.1006-0111.2012.01.008
[13]	陈岳祥, 乔艳, 乔化民, 姚建忠. HPLC法测定粉背雷公藤中雷公藤甲素的含量 . 药学实践与服务, 2009, 27(2): 134-136.
[14]	吴忠斌, 陈建明. 脂质体包裹血红蛋白的制备方法及质量影响因素 . 药学实践与服务, 2008, (1): 1-4.
[15]	许重远, 刘世霆, 侯连兵, 陈志良. 双氯芬酸钠脂质体凝胶剂的研制 . 药学实践与服务, 2002, (1): 19-20.
[16]	陈建明, 张仰眉, 高申. 受脂质体作为药物载体的研究进展 . 药学实践与服务, 2001, (4): 214-218.
[17]	郑永红, 全东琴. 地塞米松脂质体质量控制方面的研究 . 药学实践与服务, 2001, (2): 86-88.
[18]	张荣, 胡永狮, 刘标生, 汤秋华. 雷公藤口服液质量控制方法的研究 . 药学实践与服务, 2001, (5): 301-303.
[19]	孙华君, 朱全刚, 胡晋红. 脂质体经皮给药研究进展 . 药学实践与服务, 1999, (4): 221-224.
[20]	肖旭. 5-氟尿嘧啶温度敏感性脂质体制备方法的优化 . 药学实践与服务, 1998, (6): 344-346.

点击查看大图

计量

文章访问数: 3051
HTML全文浏览量: 237
PDF下载量: 576
被引次数: 0

雷公藤甲素唱硬脂酸酯的合成及其制剂成药性研究

doi: 10.3969/j.issn.1006-0111.2017.02.011

1. 福建中医药大学药学院, 福建福州 350122;第二军医大学药学院, 上海 200433

2. 第二军医大学学员旅学员6队, 上海 200433

3. 第二军医大学药学院, 上海 200433

收稿日期: 2016-12-30
修回日期: 2017-02-22

关键词:

雷公藤甲素 /

硬脂酸酯 /

前药 /

脂质体 /

脂肪乳 /

成药性

摘要: 目的合成一种雷公藤甲素脂溶性前药，以期提高其制剂的成药性。方法以4-二甲氨基吡啶（DMAP）催化的酸与醇的DCC缩合法，合成雷公藤甲素-硬脂酸酯（TP-SA），通过质谱、核磁共振氢谱和碳谱进行结构确认；采用摇瓶法测定化合物油-水分配系数；将TP及TP-SA制备成脂质体及脂肪乳，考察其初步稳定性。结果实验结果证明：成功合成TP-SA。TP-SA的log P为2.33。相同处方条件下，TP难以制备成脂质体和乳剂；TP-SA制备成脂质体粒径约90 nm，制备成脂肪乳粒径约110 nm，包封率均大于95%；4℃及25℃条件下观察TP-SA脂质体和脂肪乳的放置稳定性，1周内粒径、包封率等制剂参数皆无明显变化。结论 TP-SA显著改善药物制剂成药性，本研究可为TP制剂开发提供参考。

English Abstract

Synthesis and druggability study of triptolide stearate

1. School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China;School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. The sixth Team of Student Brigade, Second Military Medical University, Shanghai 200433, China

3. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

Received Date: 2016-12-30
Rev Recd Date: 2017-02-22

Keywords:

Abstract: Objective To synthesize a lipophilic prodrug of triptolide (TP) and improve its druggability. Methods Triptolide stearate (TP-SA) was synthesized via the DMAP-catalyzed DCC method and identified by MS, ¹H-NMR and ¹³C-NMR. The shake-flask method was used to study the oil/water partition coefficient. The preparations of TP and TP-SA liposomes and emulsions were compared. Their encapsulation efficiency and stability were investigated. Results TP-SA was synthesized successfully. Its log P in octanol/water system was 2.33. It was difficult to prepare TP liposome or emulsion. By contrast, TP-SA liposome and emulsion can be prepared successfully with the same formulation process. The particle size of TP-SA liposomes were about 90 nm and TP-SA emulsions were about 110 nm. The encapsulation efficiency was above 95%. Their stability were studied at 4℃ and 25℃. The preparation parameters, such as particle size and encapsulation efficiency, had no significant change in a week. Conclusion Triptolide stearate enhanced drug lipophilicity. Its druggability was improved significantly. These data can be used for the TP related drug design and development.